Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Withdrawn 1Unknown 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 15Gastrointestinal 9Tumor-Agnostic 4Genitourinary 4Head & Neck 3Gynecologic 3Thoracic 1Lymphoid 1Endocrine 1Dermatologic 1CNS 1

Conditions

Ovarian Neoplasms 2Uterine Cervical Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Paclitaxel 575Carboplatin 520Cisplatin 347Bevacizumab 252pembrolizumab 226Gemcitabine 157Topotecan 128liposomal doxorubicin 127Cyclophosphamide 126olaparib 120Taxes 113Radiotherapy 110Docetaxel 94Brachytherapy 89Doxorubicin 84Drug Therapy 80niraparib 75Nivolumab 71Magnetic Resonance Spectroscopy 71Specimen Handling 65fludarabine 56Biopsy 55Hyperthermic Intraperitoneal Chemotherapy 53Filgrastim 52Letrozole 50Oxaliplatin 48durvalumab 47Immunoglobulin G 47atezolizumab 46Platinum 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Decision Support Techniques × Gynecologic × Clear all
NCT05512260 2026-02-11

BESTa

Karolinska Institutet

Phase NA Withdrawn
BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT02259699 2019-06-10

PCOA

University of California, Irvine

Phase NA Completed
124 enrolled 11 charts
Gynecologic

Ovarian Neoplasms

NCT00119509 2007-04-25

The IMAP Study Improving Management of Mildly Abnormal Pap Smears

University of Sydney

Phase 3 Unknown
300 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡